|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 09815707.6 (espacenet) (Federated) (European Patent Register), 20090918 | | Patent/reg. no. and date | DK/EP 2333110, 20141119 | | Publication date | 20110615 | | Priority no. and date | ES 200802713, 20080924 | | EP pub. no. and date |
EP 2333110 20110615 | | Effective date | | | Applicant/owner | Fundacio Institut de Recerca de l'Hospital
Universitari Vall d'Hebron, Passeig Vall d'Hebron, 119-129
08035 Barcelona, ES | | Applicant ref. no. | ET-31886/EP/DK | | Inventor | MARSAL BARRIL, Sara, Passeig Vall d'Hebron 119-129
E-08035 Barcelona, ES,
JULIÃ? CANO, Antonio, Passeig Vall d'Hebron 119-129
E-08035 Barcelona, ES | | Representative | Dennemeyer & Associates S.A, P.O. Box 700425
DE-81304 Munich, DE | | Opponent | | | IPC Class | C12Q 1/68 (2006.01) | | Title | IN VITRO-FREMGANGSMÅDE TIL PROGNOSTICERING ELLER FORUDSIGELSE AF RESPONS FRA PATIENTER MED REUMATOID ARTHRITIS PÅ BEHANDLING MED TNF-alfa-FAKTOR-BLOKERENDE MIDLER | | Int. application no. | ES2009070388 | | Int. publication no. | WO2010034864 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
